Viewing Study NCT00262795


Ignite Creation Date: 2025-12-24 @ 1:33 PM
Ignite Modification Date: 2026-01-04 @ 2:21 PM
Study NCT ID: NCT00262795
Status: COMPLETED
Last Update Posted: 2019-05-23
First Post: 2005-12-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
Sponsor: German CLL Study Group
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CLL5
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators